NCT05521984 2026-04-02Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)Washington University School of MedicinePhase 1 Recruiting20 enrolled